Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.typeArtigo de periódicopt_BR
dc.titleComplexation Of 50% Enantiomeric Excess (s75-r25) Bupivacaine With Cyclodextrins And Spinal Block Anesthesia In Rats [mistura Com Excesso Enantiomérico De 50% (s75-r25) De Bupivacaína Complexada Com Ciclodextrinas E Anestesia Por Via Subaracnóidea Em Ratos]pt_BR
dc.contributor.authorDe Araujo D.R.pt_BR
dc.contributor.authorBraga A.D.F.D.A.pt_BR
dc.contributor.authorMoraes C.M.pt_BR
dc.contributor.authorFraceto L.F.pt_BR
dc.contributor.authorDe Paula E.pt_BR
unicamp.authorDe Araujo, D.R., Biologia Funcional e Molecular - Bioquímica, Instituto de Biologia-UNICAMP, Brazil, Depto. de Bioquímica, Instituto de Biologia, C. Universitaria Zeferino Vaz s/n, 13083-970 Campinas, SP, Brazilpt_BR
unicamp.authorBraga, A.D.F.D.A., Departamento de Anestesiologia, FCM-UNICAMP, Brazilpt_BR
unicamp.authorDe Paula, E., Departamento de Bioquímica, Instituto de Biologia, UNICAMP, Brazilpt_BR, C.M., Farmácia, Universidade de Sorocaba, Brazilpt, L.F., Farmácia, Universidade de Sorocaba, Brazilpt
dc.description.abstractBACKGROUND AND OBJECTIVES: In order to prolong the action and reduce systemic toxicity, formulations of local anesthetic (LA) complexed with cyclodextrins (CD) have been developed. This study determined the physical-chemical characterization and evaluated the effects of inclusion complexes of racemic bupivacaine (S50-R50) and 50% enantiomeric excess (S75-R25) bupivacaine with hydroxypropil-beta-cyclodextrin (HP-β-CD) in rats, and comparing them with the solutions currently used in the clinical practice. METHODS: Inclusion complexation of S75-R25 with HP-β-CD (equimolar ratio 1:1) was characterized by phase-solubility studies varying the concentrations of HP-β-CD and the temperature. Affinity constants (K) for HP-β-CD and the thermodynamic parameters for complexation were determined. Motor and sensitive anesthesias were evaluated through the subarachnoid administration of the formulations in the concentration of 0.5%. RESULTS: Inclusion complexation was observed through the increase in aqueous solubility of LA in different temperatures and concentrations of HP-β-CD. The in vivo tests demonstrated that S50-R50 HP-β-CD and S75-R25 HP-β-CD reduced latency (p < 0.001) without changing the recovery time of the motor block, time for maximal effect, and total effect of the drugs. Besides, both formulations increased the intensity (1.5 times, p < 0.001) and prolonged the duration of analgesia compared to the free drugs. CONCLUSIONS: The complexes S50-R50 HP-β-CD and S75-R25 HP-β-CD potentiated the differential nervous block, and can be used to reduce the frequency of administration or the dose of the LA to induce the same effect. The formulation containing enantiomeric excess (S75-R25) bupivacaine showed to be interesting in the development of safer formulations, and useful for the treatment of acute pain in the postoperative period. © Sociedade Brasileira de Anestesiologia, 2006.en
dc.relation.ispartofRevista Brasileira de Anestesiologiapt_BR
dc.identifier.citationRevista Brasileira De Anestesiologia. , v. 56, n. 5, p. 495 - 506, 2006.pt_BR
dc.description.provenanceMade available in DSpace on 2015-06-30T18:05:33Z (GMT). No. of bitstreams: 1 2-s2.0-33749640222.pdf: 350478 bytes, checksum: 6c3b786951e0376d66453e1c988d3c60 (MD5) Previous issue date: 2006en
dc.description.provenanceMade available in DSpace on 2015-11-26T14:22:29Z (GMT). No. of bitstreams: 2 2-s2.0-33749640222.pdf: 350478 bytes, checksum: 6c3b786951e0376d66453e1c988d3c60 (MD5) 2-s2.0-33749640222.pdf.txt: 56297 bytes, checksum: e8132f2f707de168a61a5bb7b7ddbe48 (MD5) Previous issue date: 2006en
dc.description.referenceCovino, B.G., Pharmacology of local anaesthetic agents (1986) Br J Anaesth, 58, pp. 701-716pt_BR
dc.description.referenceSimonetti, M.P.B., Valinetti, E.A., Ferreira, F.M., Avaliação da atividade anestésica local da S(-) bupivacaína: Estudo experimental in vivo em nervo isquiático de rato (1997) Rev Bras Anestesiol, 47, pp. 425-434pt_BR
dc.description.referenceFromming, K.H., Szejtli, J., (1994) Topics in Inclusion Science - Cyclodextrins in Pharmacy, pp. 33-34. , Hungria, Kluwer Academic Publisherspt_BR
dc.description.referenceGould, S., Scott, R.C., 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): A toxicology review (2005) Food Chem Toxicol, pp. 1451-1459pt_BR
dc.description.referenceSzejtli, J., Medicinal applications of cyclodextrins (1994) Med Res Rev, 14, pp. 353-386pt_BR
dc.description.referenceAraujo, D.R., Pinto, L.M.A., Braga, A.F.A., Formulações de anestésicos locais de liberação controlada: Aplicações terapêuticas (2003) Rev Bras Anestesiol, 53, pp. 663-671pt_BR
dc.description.referenceDollo, G., Le Corre, P., Chevanne, F., Inclusion complexation of amide-type local anesthetics with β-cyclodextrin and derivates. I. Physicochemical characterization (1996) Int J Pharm, 131, pp. 219-228pt_BR
dc.description.referenceDollo, G., Le Corre, P., Chevanne, F., Inclusion complexation of amide-type local anesthetics with β-cyclodextrin and derivates. II. Evaluation of affinity constants and in vitro transfer rate constants (1996) Int J Pharm, 136, pp. 65-74pt_BR
dc.description.referenceDollo, G., Thompson, D.O., Le Corre, P., Inclusion complexation of amide-type local anesthetics with β-cyclodextrin and derivates. III. Biopharmaceutics of bupivacaine-SBE7- β-CD complex following percutaneous sciatic nerve administration in rabbits (1998) Int J Pharm, 164, pp. 11-19pt_BR
dc.description.referenceDollo, G., Le Corre, P., Freville, J.C., Biopharmaceutics of local anesthetic-cyclodextrin complexes following loco-regional administration (2000) Ann Pharm Fr, 58, pp. 425-432pt_BR
dc.description.referenceEstebe, J.P., Ecoffey, C., Dollo, G., Bupivacaine pharmacokinetics and motor blockade following epidural administration of the bupivacaine-sulphobutylether 7-β-cyclodextrin complex in sheep (2002) Eur J Anaesthesiol, 19, pp. 308-310pt_BR
dc.description.referenceAraujo, D.R., Pinto, L.M.A., Braga, A.F.A., Sistemas de liberação controlada com bupivacaína racêmica (S50-R50) e mistura enantiomérica de bupivacaína (S75-R25): Efeitos da complexação com ciclodextrinas no bloqueio do nervo isquiático em camundongos (2005) Rev Bras Anestesiol, 55, pp. 316-328pt_BR
dc.description.referenceHiguchi, T., Connors, K.A., Phase-solubility techniques (1965) Adv Anal Chem Instr, 4, pp. 117-212pt_BR
dc.description.referenceDe Paula, E., Schreier, S., Use of a novel method for determination of partition coefficients to compare the effect of local anesthetics on membrane structure (1995) Biochim Biophys Acta, 1240, pp. 25-33pt_BR
dc.description.referenceRavelet, C., Ravel, A., Grosset, C., Stoichiometry and formation constants of six PAHs with γ-Ciclodextrin, determined by HPLC using a cyano stacionary phase (2002) J Liq Chrom Relat Technol, 25, pp. 421-432pt_BR
dc.description.referenceIsmaili, L., Andre, C., Nicod, L., Chromatographic determination of the association constants between Psorasolen derivatives and modified β-cyclodextrin: Effect of sucrose as a co-enhancer association agent (2003) J Liq Chrom Relat Technol, 26, pp. 871-882pt_BR
dc.description.referenceGazpio, C., Sanchez, M., Garcia-Zubiri, HPLC and Solubility study of the interaction between pindolol and cyclodextrins (2005) J Pharm Biomed Anal, 9, pp. 487-492pt_BR
dc.description.referenceMestre, C., Pelissier, T., Fialip, J., A method to perform direct transcutaneous intrathecal injection in rats (1994) J Pharm Toxic Meth, 32, pp. 197-200pt_BR
dc.description.referenceFeldman, H.S., Covino, B.G., Comparative motor-blocking effects of bupivacaine and ropivacaine, a new amino amide local anesthetic, in the rat and dog (1988) Anesth Analg, 67, pp. 1047-1052pt_BR
dc.description.referenceRandall, L.O., Selitto, J.J., A method for measurement of analgesic activity of inflamed tissue (1957) Archiv Int Pharmacodyn, pp. 409-419pt_BR
dc.description.referenceZar, J.H., (1996) Biostatistical Analysis, 3 rd Ed, pp. 180-216. , New Jersey, Prentice-Hallpt_BR
dc.description.referenceBibby, D., Davies, N.M., Tucker, I.G., Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems (2000) Int J Pharmac, 197, pp. 1-11pt_BR
dc.description.referenceDavis, M.E., Brewster, M.E., Cyclodextrin-based pharmaceutics: Past, present and future (2004) Nature Reviews, 3, pp. 1023-1035pt_BR
dc.description.referenceKuzma, P.J., Kline, M.D., Calkins, M.D., Progress in the development of ultra-long-acting local anesthetics (1997) Reg Anesth, 22, pp. 543-551pt_BR
dc.description.referenceBoersma, F.P., Meert, T.F., Vercauteren, M., Spinal sufentanil in rats: Part I: Epidural versus intrathecal sufentanil and morphine (1992) Acta Anaesthesiol Scand, 36, pp. 187-192pt_BR
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
2-s2.0-33749640222.pdf342.26 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.